Table 1.
Characteristics of the study population.
| Variables | |
|---|---|
| Age (years) | 58 (52–62) |
| Male gender (n, %) | 34 (82.9%) |
| BSA (m2) | 1.97 ± 0.21 |
| Smokers (n, %) | 17 (41.4%) |
| Dyslipidemia (n, %) | 27 (65.9%) |
| Diabetes (n, %) | 10 (24.4%) |
| Hypertension (n, %) | 14 (34.1) |
| Obesity (BMI > 30 kg/mq) | 11 (26.8%) |
| CKD (eGFR < 60 mL/min/1.73 mq; n, %) | 8 (19.5%) |
| Atrial fibrillation (n, %) | 16 (39.0%) |
| ICD (n, %) | 35 (85.4%) |
| Etiology of HF | |
| Ischemic (n, %) | 16 (39.0%) |
| Nonischemic (n, %) | 25 (61.0%) |
| NYHA class | |
| Class I (n, %) | 6 (14.6%) |
| Class II (n, %) | 25 (61.0%) |
| Class III (n, %) | 10 (24.4%) |
| Class IV (n, %) | 0 (0.0%) |
| Hb (g/dL) | 14.2 ± 1.5 |
| WBC (×109/L) | 7.48 (6.38–9.24) |
| Creatinine (mg/dL) | 1.14 ± 0.23 |
| Bilirubin (mg/dL) | 0.7 (0.4–0.9) |
| NT-proBNP (pg/mL) | 1522 (649–2550) |
Data are expressed as mean ± DS or median (IQR)]. BSA, body surface area; BMI, body mass index; CKD, chronic kidney disease; eGFR, estimated glomerular filtration ratio; COPD, chronic obstructive pulmonary disease; ICD, implantable cardioverter defibrillator; HF, heart failure; Hb, hemoglobin; WBC, white blood cells; NT-proBNP, N-terminal pro–B-type natriuretic peptide.